A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/115 (2006.01) A61K 31/711 (2006.01)
Patent
CA 2584457
Antisense oligonucleotides for treating and/or preventing at least one of asthma, allergy, hypereosinophilia, general inflammation and cancer are provided. The oligonucleotides are directed against nucleic acid sequences coding for a receptor selected from the group consisting of a CCR3 receptor and a common sub-unit of IL-3, IL-5 and GM-CSF receptors.
Oligonucléotides antisens pour le traitement et/ou la prévention d'au moins une des pathologies suivantes: l'asthme, l'allergie, l'hyperéosinophilie, l'inflammation générale et le cancer. Les oligonucléotides sont dirigés contre les séquences d'acide nucléique codant un récepteur sélectionné dans le groupe constitué d'un récepteur CCR3 et d'une sous-unité commune de récepteurs IL-3, IL-5 et GM-CSF.
Renzi Paolo
Zemzoumi Khalid
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Topigen Pharmaceuticals Inc.
LandOfFree
Antisense oligonucleotides for treating allergy and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides for treating allergy and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides for treating allergy and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1429378